Peter1469
11-10-2020, 09:50 AM
NAC’s Crucial Role in Preventing and Treating COVID-19 (https://articles.mercola.com/sites/articles/archive/2020/11/10/coronavirus-n-acetylcysteine.aspx?cid_source=prnl&cid_medium=email&cid_content=art1HL&cid=20201110Z1&mid=DM706785&rid=1007866966)
N-acetylcysteine (NAC) has been used by doctors primarily for acetaminophen poisoning. It is also good for liver health. It seems it is also good for preventing and treating COVID-19.
STORY AT-A-GLANCE
N-acetylcysteine (NAC) is a precursor to reduced glutathione, which appears to play a crucial role in COVID-19. There’s evidence glutathione deficiency may worsen COVID-19 severity
Patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency are more prone to COVID-19 as it depletes glutathione. Some of these patients are also at increased risk of hemolytic anemia when given the COVID-19 drug hydroxychloroquine
High-dose intravenous NAC may address the chain of events leading to red blood cell hemolysis in these patients, allowing them to recover from severe COVID-19
NAC also inhibits expression of proinflammatory cytokines, improves T cell response, benefits a variety of lung problems, and inhibits the hypercoagulation that can result in stroke and/or blood clots that impair the ability to exchange oxygen in the lungs
As the benefits of NAC against COVID-19 are starting to become known, the U.S. Food and Drug Administration is suddenly cracking down on NAC, claiming it is excluded from the definition of a dietary supplement
Read the article at the link.
N-acetylcysteine (NAC) has been used by doctors primarily for acetaminophen poisoning. It is also good for liver health. It seems it is also good for preventing and treating COVID-19.
STORY AT-A-GLANCE
N-acetylcysteine (NAC) is a precursor to reduced glutathione, which appears to play a crucial role in COVID-19. There’s evidence glutathione deficiency may worsen COVID-19 severity
Patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency are more prone to COVID-19 as it depletes glutathione. Some of these patients are also at increased risk of hemolytic anemia when given the COVID-19 drug hydroxychloroquine
High-dose intravenous NAC may address the chain of events leading to red blood cell hemolysis in these patients, allowing them to recover from severe COVID-19
NAC also inhibits expression of proinflammatory cytokines, improves T cell response, benefits a variety of lung problems, and inhibits the hypercoagulation that can result in stroke and/or blood clots that impair the ability to exchange oxygen in the lungs
As the benefits of NAC against COVID-19 are starting to become known, the U.S. Food and Drug Administration is suddenly cracking down on NAC, claiming it is excluded from the definition of a dietary supplement
Read the article at the link.